Equity Profile

GRDN

Guardian Pharmacy Services, Inc.

Health CareHealth Care Services$2.6B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, focusing on providing pharmacy services to long-term care facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of a company's profitability and will help gauge how well Guardian is managing costs and generating revenue.

N/A

Revenue Growth

Revenue growth is essential to understand the company's ability to expand its market share and maintain its competitive edge in the health care services industry.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

GRDN Q2-2026 Earnings Preview

Context

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, focusing on providing pharmacy services to long-term care facilities. As the demand for specialized health care services grows, Guardian plays a crucial role in ensuring that patients receive the medications they need in a timely and efficient manner.

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+28.09%

Avg Stock Reaction

+0.16%

Last Quarter Recap

In Q1-2026, Guardian reported an EPS of $0.29, beating estimates by 31.82%. Despite the positive earnings surprise, the stock saw a slight decline of 1.77% the following day.

Management Promises & Guidance

Continued focus on improving operational efficiencies.
Commitment to enhancing customer service and satisfaction.
Plans to explore new market opportunities in the health care sector.

Expectations

Wall Street Expectations

Overall, expectations for Guardian's upcoming earnings are mixed, with the market anticipating potential volatility given the historical performance.

Bull Case

If Guardian continues its trend of beating EPS estimates, it could signal strong operational performance and growth, leading to positive investor sentiment.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and lead to a sell-off.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given Guardian's history of beating EPS estimates, this number will be crucial in determining market sentiment and stock movement.

What is the outlook for revenue growth in the coming quarters?

Understanding the revenue trajectory will help investors gauge the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Guardian's ability to leverage its operational efficiencies, which could lead to stronger-than-expected earnings this quarter.

Supporting Evidence

Guardian has consistently beaten EPS estimates in recent quarters, indicating strong management execution.

The health care services sector is experiencing increased demand, which may not be fully reflected in current market expectations.

Key Risk

If the EPS comes in below $0.25, it could invalidate the bullish thesis and lead to a reassessment of the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on Guardian's ability to maintain its earnings momentum and provide a positive outlook amidst market uncertainties.

Bull Confirmed If

An EPS of $0.32 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.25 would confirm the bear case, raising concerns about profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±24.54%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect notable volatility around the earnings report.

Options are pricing ±11.5% while GRDN has averaged ±1.5% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

25.9%

Calls (3K)P/C Ratio: 1.00Puts (300)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Guardian beats expectations, history suggests the stock could see a modest increase of around 0.16%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

Should the company miss expectations, history suggests a potential decline, with an average move of around -1.77% following previous misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiencies and cost management strategies.
2Insights into customer satisfaction and service enhancements.
3Details on new market opportunities and expansion plans.
4Guidance on revenue expectations for the next quarter.
5Management's commentary on industry trends and competitive landscape.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Tempus AI, Inc.

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, focusing on providing pharmacy services to long-term care facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of a company's profitability and will help gauge how well Guardian is managing costs and generating revenue.

N/A

Revenue Growth

Revenue growth is essential to understand the company's ability to expand its market share and maintain its competitive edge in the health care services industry.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

GRDN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+28.09%

Avg Stock Reaction

+0.16%

Last Quarter Recap

In Q1-2026, Guardian reported an EPS of $0.29, beating estimates by 31.82%. Despite the positive earnings surprise, the stock saw a slight decline of 1.77% the following day.

Management Promises & Guidance

Continued focus on improving operational efficiencies.
Commitment to enhancing customer service and satisfaction.
Plans to explore new market opportunities in the health care sector.

Expectations

Wall Street Expectations

Overall, expectations for Guardian's upcoming earnings are mixed, with the market anticipating potential volatility given the historical performance.

Bull Case

If Guardian continues its trend of beating EPS estimates, it could signal strong operational performance and growth, leading to positive investor sentiment.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and lead to a sell-off.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given Guardian's history of beating EPS estimates, this number will be crucial in determining market sentiment and stock movement.

What is the outlook for revenue growth in the coming quarters?

Understanding the revenue trajectory will help investors gauge the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Guardian's ability to leverage its operational efficiencies, which could lead to stronger-than-expected earnings this quarter.

Supporting Evidence

Guardian has consistently beaten EPS estimates in recent quarters, indicating strong management execution.

The health care services sector is experiencing increased demand, which may not be fully reflected in current market expectations.

Key Risk

If the EPS comes in below $0.25, it could invalidate the bullish thesis and lead to a reassessment of the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on Guardian's ability to maintain its earnings momentum and provide a positive outlook amidst market uncertainties.

Bull Confirmed If

An EPS of $0.32 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.25 would confirm the bear case, raising concerns about profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±24.54%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect notable volatility around the earnings report.

Options are pricing ±11.5% while GRDN has averaged ±1.5% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

25.9%

Calls (3K)P/C Ratio: 1.00Puts (300)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Guardian beats expectations, history suggests the stock could see a modest increase of around 0.16%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

Should the company miss expectations, history suggests a potential decline, with an average move of around -1.77% following previous misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiencies and cost management strategies.
2Insights into customer satisfaction and service enhancements.
3Details on new market opportunities and expansion plans.
4Guidance on revenue expectations for the next quarter.
5Management's commentary on industry trends and competitive landscape.